Jazz Pharmaceuticals reports positive data from TONES 2 trial of JZP-110 in narcolepsy

Irish biopharmaceutical firm Jazz Pharmaceuticals has reported positive efficacy results from the Phase III TONES 2 clinical trial of JZP-110 to treat adults with narcolepsy-associated excessive sleepiness.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news